...
首页> 外文期刊>Investigative ophthalmology & visual science >Culture Systems of Dissociated Mouse and Human Pluripotent Stem Cella??Derived Retinal Ganglion Cells Purified by Two-Step Immunopanning
【24h】

Culture Systems of Dissociated Mouse and Human Pluripotent Stem Cella??Derived Retinal Ganglion Cells Purified by Two-Step Immunopanning

机译:两步免疫纯化纯化的小鼠和人多能干细胞分离的视网膜神经节细胞的培养系统

获取原文
           

摘要

Purpose: We aimed to establish purification and culture systems for retinal ganglion cells (RGCs) differentiated from mouse and human pluripotent stem cells (PSC) for in vitro and regenerative medicine studies. Methods: We used a two-step immunopanning method to purify RGCs from mouse and human PSC-derived three-dimensional (3D) retinal organoids. To assess the method, we purified RGCs from 3D retinal organoids derived from embryonic stem cells (ESCs) generated from Thy1-EGFP transgenic (TG) mice. In addition, 3D retinal organoids differentiated from human induced PSCs (iPSCs) were cultured for up to differentiation day (DD) 120, and RGCs were purified by immunopanning. RGC marker expressions were confirmed by immunostaining and reverse transcriptiona??quantitative PCR. The purified RGCs were cultured, and neurite outgrowth was measured and analyzed using an IncuCyte Zoom system. Results: Mouse RGCs purified from Thy1-EGFP TG mouse retinas and the ESC-derived 3D retinas could be maintained for approximately 2 to 3 weeks, expressing the markers BRN3B and SMI-312. Purified RGCs from human iPSC-derived retinal organoids expressed RGC markers and could be maintained for up to 4 weeks. The RGCs collected at DD 90 to 110 extended longer neurites than those collected at younger stages. Conclusions: We successfully purified RGCs from mouse and human PSC-derived 3D retinal organoids cultured for approximately 120 days. RGCs from older retinal organoids would be useful for neurite tracking. This method would be effective not only for studying the pathology of human RGC diseases but also for therapeutic drug studies and RGC transplantation.
机译:目的:我们旨在为从小鼠和人类多能干细胞(PSC)分化而来的视网膜神经节细胞(RGC)建立纯化和培养系统,用于体外和再生医学研究。方法:我们使用了两步免疫淘选法从小鼠和人PSC衍生的三维(3D)视网膜类器官中纯化RGC。为了评估该方法,我们从源自Thy1-EGFP转基因(TG)小鼠的胚胎干细胞(ESC)的3D视网膜类器官中纯化了RGC。此外,将由人诱导的PSC(iPSC)分化的3D视网膜类器官培养至分化日(DD)120,然后通过免疫淘选纯化RGC。通过免疫染色和逆转录定量PCR证实了RGC标志物的表达。培养纯化的RGC,并使用IncuCyte Zoom系统测量和分析神经突的长出。结果:从Thy1-EGFP TG小鼠视网膜和ESC衍生的3D视网膜中纯化的小鼠RGC可以维持大约2至3周,表达标记BRN3B和SMI-312。从人iPSC衍生的视网膜类器官中纯化的RGC可以表达RGC标记,并且可以维持长达4周。在DD 90到110收集的RGC比在年轻阶段收集的RGC延伸更长的神经突。结论:我们成功地从小鼠和人PSC衍生的3D视网膜类器官中培养了大约120天,成功地纯化了RGC。来自较老的视网膜类器官的RGC对于神经突追踪将是有用的。该方法不仅对于研究人类RGC疾病的病理学而且对于治疗药物研究和RGC移植都是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号